Press Release


May 13, 2015

ASCO accepts Real Endpoint’s abstract on RxScorecard analysis of adjuvant breast cancer therapies

Real Endpoints is pleased to announce that it will be presenting its RxScorecard on adjuvant breast cancer at ASCO’s annual meeting in June. The analysis demonstrates that its RxScorecard interactive, web-based tool can determine relative drug value using weighted measurements of efficacy, safety and use, and economics.

read full press release >